Transplantation studies in mice and rats have shown that human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) can improve the function of infarcted hearts, but two critical issues related to their electrophysiological behaviour in vivo remain unresolved. First, the risk of arrhythmias following hESC-CM transplantation in injured hearts has not been determined. Second, the electromechanic...

The recent advances in stem cell biology and tissue engineering have paved the way to the development of a new field in biomedicine, regenerative medicine. This approach seeks to circumvent the shortage of organs for transplantation, by combining the above-mentioned technologies in an attempt to replace diseased or absent tissue. The heart represents an attractive candidate for these emerging t...

The discovery of primitive cardiac stem-like cells with the ability for self-renewal and the capacity for differentiation into all cardiac cell lineages has completely changed the prevailing view of the heart as a static, terminally differentiated organ.1 Like virtually all somatic tissues, the adult heart harbors a pool of stem/progenitor cells responsible for the maintenance of organ cell hom...

The discovery of primitive cardiac stem-like cells with the ability for self-renewal and the capacity for differentiation into all cardiac cell lineages has completely changed the prevailing view of the heart as a static, terminally differentiated organ.1 Like virtually all somatic tissues, the adult heart harbors a pool of stem/progenitor cells responsible for the maintenance of organ cell hom...

The osteochondral lesion of the talus and its treatment has become an important issue over last decades. The main causes of lesion of the talus cartilage are osteochondritis dissecans, arthritis, fractures, etc. There are many operative management techniques of the cartilage repair including bone marrow cell inducing techniques such as micro fracture surgery, drilling, PDGF and graft applicatio...

Many female patients present with malignant and non-malignant conditions whose treatment causes infertility. Women who are diagnosed with neoplastic diseases before1 or during2 their reproductive years and undergo ootoxic therapies,3 those who undergo an oophorectomy due to non-malignant disorders,4 those of reproductive age at risk for premature menopause associated with genetic disorders, and...

s have been reviewed and evaluated by a scientific committee BIOCELL, 37(1) 2013 A-2 ABSTRACTS ORGANIZING COMMITTEE President Antonio Felipe Secretary Cristina Perez Treasurer Ricardo Alzola Secretary of Press and Publications Hugo Solana Members Alejandra Castro Miriam Teruel María del Carmen Díaz Susana Gomez Mónica Larsen María Eugenia Maiarú Judit Dopazo Verónica Eyheramendy Marcela Herrera...